Related Experiment Video
Updated: Feb 19, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Unexpected Survivors: Children With Life-Limiting Conditions of Uncertain Prognosis
Savithri Nageswaran1, Anna Hurst2, Andrea Radulovic3
11 Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Insights
A small group of children with life-limiting illnesses are unexpected survivors, living longer than predicted. Healthcare providers should acknowledge prognostic uncertainty and communicate it to families.
Area of Science:
- Pediatric Palliative Care
- Medical Prognostication
- Life-Limiting Illnesses
Background:
- Prognosticating survival in children with rare life-limiting illnesses is challenging due to medical advancements.
- Accurate survival predictions are difficult, impacting care planning and family support.
Purpose of the Study:
- To characterize children with life-limiting illnesses who survived longer than healthcare providers' expectations.
- To identify factors associated with unexpected long-term survival in pediatric palliative care.
Main Methods:
- Retrospective cohort study of 349 children in a pediatric palliative care program (2008-2012).
- Identified "unexpected survivors" who lived beyond prognosticated survival.
- Clinical courses were followed until September 2015 or death.
Main Results:
- Eighteen (5%) children were identified as unexpected survivors; 17 were included in the analysis.
- Congenital anomalies were the most common diagnosis; neonatal intensive care unit was the frequent prognostication setting.
- Median survival was 1.5 years for those who died and 5.9 years for those who survived beyond the study period.
Conclusions:
- Unexpected survivors represent a small but significant patient group.
- Clinicians must recognize prognostic uncertainty and communicate it openly with families.
- Supportive services are crucial when poor survival is anticipated; further research is needed.
Objective:
Prognostication of survival is difficult in children with life-limiting illnesses because of the rarity of these conditions and technological advances improving survival. The objective of this article is to describe the characteristics of children with life-limiting illnesses who survived longer than the expectations of health-care providers.
Study Design:
This is a retrospective cohort study conducted in a tertiary-care children's hospital in North Carolina. "Unexpected survivors," defined as children who survived despite a prognosis of imminent death or significantly longer than prognosticated by health-care providers, were identified from among 349 children enrolled in a pediatric palliative care program between March 2008 and October 2012. Children's clinical courses were followed until September 2015 or their death.
Results:
Eighteen (5%) children were identified as unexpected survivors; 17 (10 girls and 7 boys) were included. Congenital anomalies were the most common diagnoses. Neonatal intensive care unit was the most frequent setting of prognostication. Thirteen children used some form of medical technology at the time of prognostication. Eleven children received hospice services. Eight died during the observation period but survived significantly longer than expected (median survival time 1.5 years), and 9 survived beyond the observation period (median survival time 5.9 years).
Conclusions:
Unexpected survivors are a small group of children with life-limiting conditions. Clinicians should be aware of the possibility of prognostic inaccuracy, able to communicate prognostic uncertainty to parents, and engage supportive services when prognosticating poor survival. Prospective studies are needed to understand outcomes of children with life-limiting illnesses of uncertain prognosis.
Related Concept Videos
Assumptions of Survival Analysis
Cancer Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kidney Transplant I: Introduction
Life Tables
Pharmacokinetics in Pediatric Patients: Drug Excretion

